UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6426
ARB IOT Group
ARBB
$7.13M
| $68.6K | ﹤0.01% |
+8,404
| New | +$114K |
|
6427
Clarus
CLAR
$148M
| $68.5K | ﹤0.01% |
10,183
-25,268
| -71% | -$167K |
|
|
DOCT
6428
FT Vest US Equity Deep Buffer ETF October
DOCT
$388M
| $68.5K | ﹤0.01% |
1,785
+666
| +60% | +$25.2K |
|
|
SPRB
6429
Spruce Biosciences
SPRB
$128M
| $68.3K | ﹤0.01% |
1,759
+1,548
| +734% | +$83K |
|
|
NXDT
6430
NexPoint Diversified Real Estate Trust
NXDT
$241M
| $68.2K | ﹤0.01% |
12,338
-38,039
| -76% | -$217K |
|
6431
Fidelity Quality Factor ETF
FQAL
$1.46B
| $68.2K | ﹤0.01% |
+1,112
| New | +$65.3K |
|
6432
Innoviz Technologies
INVZ
$110M
| $68.2K | ﹤0.01% |
73,552
+9,905
| +16% | +$11.1K |
|
6433
Ceragon Networks
CRNT
$202M
| $68.1K | ﹤0.01% |
27,220
+10,261
| +61% | +$28.1K |
|
|
MXF
6434
Mexico Fund
MXF
$318M
| $67.8K | ﹤0.01% |
4,238
+1,911
| +82% | +$33.9K |
|
|
BLUE
6435
DELISTED
bluebird bio
BLUE
| $67.5K | ﹤0.01% |
3,428
-7,528
| -69% | -$151K |
|
6436
Dimensional Core Fixed Income ETF
DFCF
$10.9B
| $67.4K | ﹤0.01% |
+1,623
| New | +$67.2K |
|
6437
CCSC Technology International Holdings
CCTG
$9.44M
| $67.4K | ﹤0.01% |
+2,821
| New | +$69K |
|
6438
BioXcel Therapeutics
BTAI
$26.9M
| $67.2K | ﹤0.01% |
3,280
-5,917
| -64% | -$198K |
|
6439
Viant Technology
DSP
$266M
| $67.1K | ﹤0.01% |
6,799
-10,078
| -60% | -$94K |
|
6440
VistaGen Therapeutics
VTGN
$13.2M
| $67K | ﹤0.01% |
19,266
+14,530
| +307% | +$62.9K |
|
6441
ADC Therapeutics
ADCT
$144M
| $67K | ﹤0.01% |
21,193
+21,142
| +41,455% | +$84K |
|
6442
Dynagas LNG Partners
DLNG
$136M
| $66.9K | ﹤0.01% |
16,612
-1,128
| -6% | -$4.17K |
|
6443
Codexis
CDXS
$160M
| $66.9K | ﹤0.01% |
21,573
-51,757
| -71% | -$166K |
|
|
KRNL
6444
DELISTED
Kernel Group Holdings, Inc. Class A Ordinary Shares
KRNL
| $66.7K | ﹤0.01% |
+6,056
| New | +$66.1K |
|
|
NXG.RT
6445
DELISTED
NXG NextGen Infrastructure Income Fund Rights (expiring July 17, 2024)
NXG.RT
| $66.7K | ﹤0.01% |
+121,323
| New | +$69.2K |
|
|
FCO
6446
DELISTED
abrdn Global Income Fund
FCO
| $66.7K | ﹤0.01% |
11,481
+7,381
| +180% | +$41.7K |
|
6447
BayCom
BCML
$335M
| $66.6K | ﹤0.01% |
3,275
-7,511
| -70% | -$149K |
|
6448
Puma Biotechnology
PBYI
$431M
| $66.3K | ﹤0.01% |
20,327
+9,684
| +91% | +$42.5K |
|
6449
Adaptive Hedged Multi-Asset Income ETF
AMAX
$68.7M
| $66.2K | ﹤0.01% |
8,423
+6,386
| +314% | +$50.8K |
|
|
XNET
6450
Xunlei
XNET
$324M
| $66.1K | ﹤0.01% |
39,364
+23,591
| +150% | +$39.4K |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.